Martin Marietta Materials, Inc. MLM
Verdict: Sell. Fair value $488 against a price of $642 on 6 Jan 2026, 24% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power.
The case against: In 2024, Net Income was $2.00B while Operating Cash Flow was only $1.46B, resulting in a poor.... Net Income surged by 71% (from $1.17B to $2.00B) in 2024, while Revenue simultaneously declined by.... The Accruals Ratio flipped from negative (cash-generative) in 2023 (-0.020) and 2022 (-0.007) to....
Main risks
- Revenue Deceleration: TTM revenue declined ~2.1% vs the prior year, a sharp reversal from the 3-year CAGR of 6.5%, signaling potential market headwinds or loss of pricing power.
- Anomalous 2024 Net Income: Net margin spiked to an unsustainable 30.6% in 2024 from 17.3% in 2023 despite lower revenue, suggesting a large, non-recurring gain is distorting profitability metrics like ROE.
- Poor Return on Invested Capital (ROIC): The estimated TTM ROIC of 6.3% is low for a capital-intensive business and likely below the company's cost of capital, indicating inefficient use of its large capital base.
- In 2024, Net Income was $2.00B while Operating Cash Flow was only $1.46B, resulting in a poor...
- Net Income surged by 71% (from $1.17B to $2.00B) in 2024, while Revenue simultaneously declined by...
- In 2024, Net Income was $2.00B while Operating Cash Flow was only $1.46B, resulting in a poor OCF/NI ratio of 0.73. This indicates that $540M of reported earnings did not convert to cash, a significant deterioration from prior years (ratios of 1.31 and 1.14).